Drug intelligence / Profile preview

New Retin

Development stage: Preclinical
Lead developer: LYS PHARMA
Modality: Small Molecules
Administration: Oral

Overview

New Retin is a dietary supplement (health functional food) developed and marketed by the South Korean company LYS PHARMA. Its primary active ingredient is L-carnitine, typically provided in the form of L-carnitine tartrate. The product is specifically positioned for use in patients with diabetic retinopathy, where it is intended to support retinal health through its role in mitochondrial fatty acid metabolism and its potential antioxidant properties. L-carnitine acts as a vital carrier molecule, transporting long-chain fatty acids across the inner mitochondrial membrane for energy production via beta-oxidation. Beyond ophthalmology, New Retin has been associated with research into pregnancy outcomes, including its mention in Cochrane reviews regarding the prevention of preterm birth through L-carnitine supplementation.

Brand names: New Retin뉴레틴
Other names: New Retin BottleL-carnitine tartrate

Targets

SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on New Retin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Retin.

Explore the full profile